Diabeloop and SOOIL launch DBLG1 with Dana-i Pump in Germany, Distributed by Mediq

Grenoble, France, July 2025

Diabeloop Announces Commercial Availability of DBLG1 with Dana-i Insulin Pump in Germany

Diabeloop is pleased to announce the commercial availability of its DBLG1 algorithm with the Dana-i insulin pump from SOOIL in Germany. The system is distributed through Mediq, a leading provider in the European diabetes market. Mediq has been appointed as the exclusive distributor for the DBLG1 system and the Dana-i pump by SOOIL.

The Dana-i is the latest version of the trusted and user-friendly Dana pump, making it an excellent match for Diabeloop’s DBLG1 self-learning algorithm. Mediq will support the German rollout with high-quality customer service and training.
The initial launch phase will be for patients using already a Dexcom G6 CGM

“We are committed to offering more choices to people with diabetes,” said Cécile Ferracci, Chief Commercial Officer of Diabeloop. “Thanks to this partnership with SOOIL—an outcome of our interoperability strategy—we are proud to now offer three options to patients in Germany: DBLG1 with Accu-Chek Insight (Roche), DBLG1 with Kaleido (Vicentra), and DBLG1 with Dana-i. All three systems are integrated with the Dexcom G6 continuous glucose monitor.” 

“Our next step in Europe is the upcoming launch of DBLG2, the version available on patients’ smartphones, paired with the Dexcom G7.”